Correction: Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
entrez: 12 4 2019
pubmed: 12 4 2019
medline: 12 4 2019
Statut: epublish

Résumé

[This corrects the article DOI: 10.1371/journal.pone.0212989.].

Identifiants

pubmed: 30973957
doi: 10.1371/journal.pone.0215491
pii: PONE-D-19-09519
pmc: PMC6459474
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

e0215491

Commentaires et corrections

Type : ErratumFor

Références

PLoS One. 2019 Feb 26;14(2):e0212989
pubmed: 30807613

Auteurs

Classifications MeSH